138 related articles for article (PubMed ID: 24092923)
1. SH2B3: a new leukemia predisposition gene.
Willman CL
Blood; 2013 Oct; 122(14):2293-5. PubMed ID: 24092923
[TBL] [Abstract][Full Text] [Related]
2. Genetic loss of SH2B3 in acute lymphoblastic leukemia.
Perez-Garcia A; Ambesi-Impiombato A; Hadler M; Rigo I; LeDuc CA; Kelly K; Jalas C; Paietta E; Racevskis J; Rowe JM; Tallman MS; Paganin M; Basso G; Tong W; Chung WK; Ferrando AA
Blood; 2013 Oct; 122(14):2425-32. PubMed ID: 23908464
[TBL] [Abstract][Full Text] [Related]
3. Co-existence of IL7R high and SH2B3 low expression distinguishes a novel high-risk acute lymphoblastic leukemia with Ikaros dysfunction.
Ge Z; Gu Y; Xiao L; Han Q; Li J; Chen B; Yu J; Kawasawa YI; Payne KJ; Dovat S; Song C
Oncotarget; 2016 Jul; 7(29):46014-46027. PubMed ID: 27322554
[TBL] [Abstract][Full Text] [Related]
4. Deep targeted sequencing in pediatric acute lymphoblastic leukemia unveils distinct mutational patterns between genetic subtypes and novel relapse-associated genes.
Lindqvist CM; Lundmark A; Nordlund J; Freyhult E; Ekman D; Carlsson Almlöf J; Raine A; Övernäs E; Abrahamsson J; Frost BM; Grandér D; Heyman M; Palle J; Forestier E; Lönnerholm G; Berglund EC; Syvänen AC
Oncotarget; 2016 Sep; 7(39):64071-64088. PubMed ID: 27590521
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of SH2B3 (LNK) expression in paediatric B-cell precursor acute lymphoblastic leukaemia.
Yano M; Imamura T; Asai D; Deguchi T; Hashii Y; Endo M; Sato A; Kawasaki H; Kosaka Y; Kato K; Hori H; Yumura-Yagi K; Hara J; Oda M; Horibe K
Br J Haematol; 2018 Oct; 183(2):327-330. PubMed ID: 29082511
[No Abstract] [Full Text] [Related]
6. SH2B3 aberrations enriched in iAMP21 B lymphoblastic leukemia.
Baughn LB; Meredith MM; Oseth L; Smolarek TA; Hirsch B
Cancer Genet; 2018 Oct; 226-227():30-35. PubMed ID: 30005852
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of novel SH2B3 mutations in adult Chinese acute lymphoblastic leukemia patients.
Gu Y; Han Q; McGrath M; Song C; Ge Z
Leuk Res; 2018 Sep; 72():67-70. PubMed ID: 30103202
[No Abstract] [Full Text] [Related]
8. Association of a single-nucleotide polymorphism in the SH2B3 gene with JAK2V617F-positive myeloproliferative neoplasms.
Lesteven E; Picque M; Conejero Tonetti C; Giraudier S; Varin-Blank N; Velazquez L; Kiladjian JJ; Cassinat B; Baran-Marszak F
Blood; 2014 Jan; 123(5):794-6. PubMed ID: 24482502
[No Abstract] [Full Text] [Related]
9. Transformation of severe congenital neutropenia to early acute lymphoblastic leukemia in a patient with HAX1 mutation and without G-CSF administration or receptor mutation.
Yetgin S; Olcay L; Koç A; Germeshausen M
Leukemia; 2008 Sep; 22(9):1797. PubMed ID: 18354489
[No Abstract] [Full Text] [Related]
10. SH2B3 inactivation through CN-LOH 12q is uniquely associated with B-cell precursor ALL with iAMP21 or other chromosome 21 gain.
Sinclair PB; Ryan S; Bashton M; Hollern S; Hanna R; Case M; Schwalbe EC; Schwab CJ; Cranston RE; Young BD; Irving JAE; Vora AJ; Moorman AV; Harrison CJ
Leukemia; 2019 Aug; 33(8):1881-1894. PubMed ID: 30816328
[TBL] [Abstract][Full Text] [Related]
11. LNK/SH2B3 regulates IL-7 receptor signaling in normal and malignant B-progenitors.
Cheng Y; Chikwava K; Wu C; Zhang H; Bhagat A; Pei D; Choi JK; Tong W
J Clin Invest; 2016 Apr; 126(4):1267-81. PubMed ID: 26974155
[TBL] [Abstract][Full Text] [Related]
12. Predisposing germline mutations in high hyperdiploid acute lymphoblastic leukemia in children.
de Smith AJ; Lavoie G; Walsh KM; Aujla S; Evans E; Hansen HM; Smirnov I; Kang AY; Zenker M; Ceremsak JJ; Stieglitz E; Muskens IS; Roberts W; McKean-Cowdin R; Metayer C; Roux PP; Wiemels JL
Genes Chromosomes Cancer; 2019 Oct; 58(10):723-730. PubMed ID: 31102422
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of CARMA1-BCL10-MALT1-A20-NF-κB expression in T cell-acute lymphocytic leukemia.
Ma Y; Liao Z; Xu Y; Zhong Z; Wang X; Zhang F; Chen S; Yang L; Luo G; Huang X; Huang S; Wu X; Li Y
Eur J Med Res; 2014 Nov; 19(1):62. PubMed ID: 25384343
[TBL] [Abstract][Full Text] [Related]
14. Monoallelic or biallelic LMO2 expression in relation to the LMO2 rearrangement status in pediatric T-cell acute lymphoblastic leukemia.
Van Vlierberghe P; Beverloo HB; Buijs-Gladdines J; van Wering ER; Horstmann M; Pieters R; Meijerink JP
Leukemia; 2008 Jul; 22(7):1434-7. PubMed ID: 18079736
[No Abstract] [Full Text] [Related]
15. The function of SH2B3 (LNK) in the kidney.
Blass G; Mattson DL; Staruschenko A
Am J Physiol Renal Physiol; 2016 Oct; 311(4):F682-F685. PubMed ID: 27440780
[TBL] [Abstract][Full Text] [Related]
16. Mutational analysis of DOK2 tumor suppressor gene in acute leukemias.
Kim MS; Chung NG; Yoo NJ; Lee SH
Leuk Res; 2011 Jun; 35(6):e87-8. PubMed ID: 21329978
[No Abstract] [Full Text] [Related]
17. Acute lymphoblastic leukemia associated with RCSD1-ABL1 novel fusion gene has a distinct gene expression profile from BCR-ABL1 fusion.
De Braekeleer E; Douet-Guilbert N; Guardiola P; Rowe D; Mustjoki S; Zamecnikova A; Al Bahar S; Jaramillo G; Berthou C; Bown N; Porkka K; Ochoa C; De Braekeleer M
Leukemia; 2013 Jun; 27(6):1422-4. PubMed ID: 23168614
[No Abstract] [Full Text] [Related]
18. Molecular characterization of identical, novel MLL-EPS15 translocation and individual genomic copy number alterations in monozygotic infant twins with acute lymphoblastic leukemia.
Kotecha RS; Ford J; Beesley AH; Anderson D; Cole CH; Kees UR
Haematologica; 2012 Sep; 97(9):1447-50. PubMed ID: 22581003
[No Abstract] [Full Text] [Related]
19. The DNA methylome of pediatric acute lymphoblastic leukemia.
Davidsson J; Lilljebjörn H; Andersson A; Veerla S; Heldrup J; Behrendtz M; Fioretos T; Johansson B
Hum Mol Genet; 2009 Nov; 18(21):4054-65. PubMed ID: 19679565
[TBL] [Abstract][Full Text] [Related]
20. A new partner gene fused to ABL1 in a t(1;9)(q24;q34)-associated B-cell acute lymphoblastic leukemia.
De Braekeleer E; Douet-Guilbert N; Le Bris MJ; Berthou C; Morel F; De Braekeleer M
Leukemia; 2007 Oct; 21(10):2220-1. PubMed ID: 17541395
[No Abstract] [Full Text] [Related]
[Next] [New Search]
